ONINTZA
SAGREDO EZQUIOGA
Profesora titular de universidad
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (7)
2018
-
Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders
Biochemical Pharmacology, Vol. 157, pp. 85-96
2014
-
A restricted population of CB1 cannabinoid receptors with neuroprotective activity
Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262
2013
-
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy
Journal of Alzheimer's Disease, Vol. 35, Núm. 3, pp. 525-539
2012
-
Cannabinoids: Novel medicines for the treatment of Huntington's disease
Recent Patents on CNS Drug Discovery, Vol. 7, Núm. 1, pp. 41-48
2011
-
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease
Brain, Vol. 134, Núm. 1, pp. 119-136
2009
-
Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
GLIA, Vol. 57, Núm. 11, pp. 1154-1167
2008
-
Role of CB2 receptors in neuroprotective effects of cannabinoids
Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2 SUPPL. 1